Clinical Trials | November 29, 2021
AMPATH launches its pathology laboratory in Mumbai
The company has has 10 existing labs in India
The company has has 10 existing labs in India
The campaign aims to increase awareness about Tuberculosis as a curable disease and promote early diagnosis.
The appraisal of the applications has been carried out based on the ranking methodology laid down in the operational guidelines of the Scheme
The Indian medical devices industry has been in focus since the pandemic. From US $ 11 billion in 2020 it is expected to touch US $ 50 billion by 2025. Mehernosh Daruwalla, Founder and MD, Lotus Surgicals shares a perspective with Thomas C Thottathil on the opportunities in this sector
The system is a compact new addition to the Roche Molecular portfolio, providing efficiency, simplicity and timely results to laboratories of all sizes.
Viyash has ten manufacturing facilities in India with a combined capacity of 2000 KL as well as one formulation facility in the US, and is now one of India’s leading mid-tier integrated API and formulation players
Two out of three people under the age of 40 are at risk of prediabetes
The US $ 192.5 mn US government contract will help fund the centre of excellence to boost the domestic supply of critically needed laboratory plastics
Aster DM Healthcare announced its financial results for the quarter ended September 30, 2021
In India, MSD has signed non-exclusive licensing agreements with eight pharma companies.
Subscribe To Our Newsletter & Stay Updated
